Literature DB >> 10918042

A guardian angel: the involvement of dipeptidyl peptidase IV in psychoneuroendocrine function, nutrition and immune defence.

M Hildebrandt1, W Reutter, P Arck, M Rose, B F Klapp.   

Abstract

Dipeptidyl peptidase IV (DPP IV, also known as CD26; EC 3.4.14.5) is a non-integrin receptor glycoprotein with multiple functions, including cell adhesion, cellular trafficking through the extracellular matrix and co-stimulatory potential during T cell activation. By virtue of its exopeptidase activity, DPP IV plays a key regulatory role in the metabolism of peptide hormones. Based on data emerging from different biomedical specialties, it appears worthwhile to highlight the different facets of DPP IV in nutrition, immune responses and peptide hormone metabolism. The presentation of the complex regulatory circuits in which DPP IV appears to be involved may also serve as a note of caution, in view of attempts to apply selective inhibitors of DPP IV enzymic activity for the treatment of disease, e.g. Type II diabetes.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10918042

Source DB:  PubMed          Journal:  Clin Sci (Lond)        ISSN: 0143-5221            Impact factor:   6.124


  14 in total

Review 1.  Cut to the chase: a review of CD26/dipeptidyl peptidase-4's (DPP4) entanglement in the immune system.

Authors:  C Klemann; L Wagner; M Stephan; S von Hörsten
Journal:  Clin Exp Immunol       Date:  2016-05-13       Impact factor: 4.330

2.  Pre- and postexposure efficacy of fully human antibodies against Spike protein in a novel humanized mouse model of MERS-CoV infection.

Authors:  Kristen E Pascal; Christopher M Coleman; Alejandro O Mujica; Vishal Kamat; Ashok Badithe; Jeanette Fairhurst; Charleen Hunt; John Strein; Alexander Berrebi; Jeanne M Sisk; Krystal L Matthews; Robert Babb; Gang Chen; Ka-Man V Lai; Tammy T Huang; William Olson; George D Yancopoulos; Neil Stahl; Matthew B Frieman; Christos A Kyratsous
Journal:  Proc Natl Acad Sci U S A       Date:  2015-06-29       Impact factor: 11.205

3.  Streptokinase promotes development of dipeptidyl peptidase IV (CD26) autoantibodies after fibrinolytic therapy in myocardial infarction patients.

Authors:  Miguel Cuchacovich; Héctor Gatica; Paula Vial; Jorge Yovanovich; Salvatore V Pizzo; Mario Gonzalez-Gronow
Journal:  Clin Diagn Lab Immunol       Date:  2002-11

4.  Heat shock protein and gliadin peptide promote development of peptidase antibodies in children with autism and patients with autoimmune disease.

Authors:  Aristo Vojdani; Mohsen Bazargan; Elroy Vojdani; John Samadi; Alen A Nourian; Navid Eghbalieh; Edwin L Cooper
Journal:  Clin Diagn Lab Immunol       Date:  2004-05

Review 5.  Weighing the evidence for a ternary protein complex mediating A-type K+ currents in neurons.

Authors:  Jonathon Maffie; Bernardo Rudy
Journal:  J Physiol       Date:  2008-10-09       Impact factor: 5.182

6.  The Evaluation of Dipeptidyl Peptidase (DPP)-IV, α-Glucosidase and Angiotensin Converting Enzyme (ACE) Inhibitory Activities of Whey Proteins Hydrolyzed with Serine Protease Isolated from Asian Pumpkin (Cucurbita ficifolia).

Authors:  Babij Konrad; Dąbrowska Anna; Szołtysik Marek; Pokora Marta; Zambrowicz Aleksandra; Chrzanowska Józefa
Journal:  Int J Pept Res Ther       Date:  2014-06-01       Impact factor: 1.931

7.  The Segregated Expression of Voltage-Gated Potassium and Sodium Channels in Neuronal Membranes: Functional Implications and Regulatory Mechanisms.

Authors:  Maël Duménieu; Marie Oulé; Michael R Kreutz; Jeffrey Lopez-Rojas
Journal:  Front Cell Neurosci       Date:  2017-04-24       Impact factor: 5.505

8.  Dipeptidylpeptidase--IV, a key enzyme for the degradation of incretins and neuropeptides: activity and expression in the liver of lean and obese rats.

Authors:  E Tarantola; V Bertone; G Milanesi; E Capelli; A Ferrigno; D Neri; M Vairetti; S Barni; I Freitas
Journal:  Eur J Histochem       Date:  2012-10-08       Impact factor: 3.188

Review 9.  Comparison of efficacy between incretin-based therapies for type 2 diabetes mellitus.

Authors:  Kaustubh Nisal; Ram Kela; Kamlesh Khunti; Melanie J Davies
Journal:  BMC Med       Date:  2012-11-30       Impact factor: 8.775

Review 10.  Emergence of the Middle East respiratory syndrome coronavirus.

Authors:  Christopher M Coleman; Matthew B Frieman
Journal:  PLoS Pathog       Date:  2013-09-05       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.